光正眼科，利空不断

Core Viewpoint - Guangzheng Eye Hospital Group announced that its controlling shareholder, Guangzheng Investment, has had 9.15 million shares frozen due to a judicial order, which represents 7.08% of its holdings and 1.78% of the company's total share capital. The freeze is effective from January 30, 2026, to January 29, 2029, and will not affect the company's control or operations significantly [1][2]. Group 1 - Guangzheng Investment's frozen shares amount to 9.15 million, accounting for 7.08% of its total holdings and 1.78% of the company's total share capital [1][2]. - The judicial freeze was initiated by the Dongguan Intermediate People's Court in Guangdong Province [2]. - The company stated that this share freeze will not lead to any change in control and that it maintains independence in assets, business, and finance [2]. Group 2 - Guangzheng Eye Hospital has reported negative net profits for 12 consecutive years from 2013 to 2024, with a projected revenue of 893 million yuan in 2024, a decline of 16.94% year-on-year [3]. - The company expects a net loss of 3 to 5 million yuan for 2025, a significant improvement compared to the previous year's loss of 175 million yuan [3]. - The company plans to enhance operational efficiency through lean management and cost control measures in its medical sector for 2025 [3]. Group 3 - As of February 6, the stock price of Guangzheng Eye Hospital closed at 4.71 yuan per share, with a total market capitalization of 2.427 billion yuan [4].